ArticleOncology letters2018

Downregulation of ROS1 enhances the therapeutic efficacy of arsenic trioxide in acute myeloid leukemia cell lines.

Jun LiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.